Company
United StatesTakeda Pharmaceuticals USA, Cambridge, MA – FDA Inspections
Inspection records and compliance data for Takeda Pharmaceuticals USA in Cambridge, Massachusetts. 3 FDA inspections on record, last inspected April 10, 2026.
Company Profile
This profile covers Takeda Pharmaceuticals USA based in Cambridge, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected March 22, 2024. Last inspected April 10, 2026.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 10, 2026 | Not classified | Human Drugs | 1313228 |
| October 16, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1253398 |
| March 22, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1231407 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Takeda Pharmaceuticals USA
FEI Number
3016418550
Address
500 Kendall St, Cambridge, Massachusetts 02142, United States
Country
United States
ID: 2cc60460-dde7-47a7-968e-c06ce6a85515